NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) (NIMRAD)
A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
Sponsor: The Christie NHS Foundation Trust
Listed as NCT01950689, this PHASE3 trial focuses on Head and Neck Squamous Cell Carcinoma and remains completed. Sponsored by The Christie NHS Foundation Trust, it has been updated 15 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2021 — Nov 2021 [monthly]
Completed PHASE3
▶ Show 10 earlier versions
-
Mar 2021 — Sep 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Jun 2019 — Aug 2020 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE3
-
Jan 2019 — May 2019 [monthly]
Recruiting PHASE3
-
Sep 2018 — Jan 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
May 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE3
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Christie NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .